Quanterix Corporation (QTRX): Price and Financial Metrics

Quanterix Corporation (QTRX): $25.94

0.93 (+3.72%)

POWR Rating

Component Grades








QTRX Price/Volume Stats

Current price $25.94 52-week high $28.77
Prev. close $25.01 52-week low $8.02
Day low $25.14 Volume 474,500
Day high $26.90 Avg. volume 341,851
50-day MA $24.81 Dividend yield N/A
200-day MA $17.86 Market Cap 974.12M

QTRX Stock Price Chart Interactive Chart >


  • QTRX scores best on the Growth dimension, with a Growth rank ahead of 96.69% of US stocks.
  • QTRX's strongest trending metric is Growth; it's been moving up over the last 177 days.
  • QTRX's current lowest rank is in the Momentum metric (where it is better than 12.19% of US stocks).

QTRX Stock Summary

  • QTRX's price/sales ratio is 8.39; that's higher than the P/S ratio of 88.34% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.2 for QUANTERIX CORP; that's greater than it is for only 13.47% of US stocks.
  • In terms of volatility of its share price, QTRX is more volatile than 86.03% of stocks we're observing.
  • Stocks that are quantitatively similar to QTRX, based on their financial statements, market capitalization, and price volatility, are VBIV, RVNC, OSS, XMTR, and SHCR.
  • QTRX's SEC filings can be seen here. And to visit QUANTERIX CORP's official web site, go to www.quanterix.com.

QTRX Valuation Summary

  • QTRX's EV/EBIT ratio is -8.9; this is 176.72% lower than that of the median Healthcare stock.
  • Over the past 70 months, QTRX's price/sales ratio has gone down 7.

Below are key valuation metrics over time for QTRX.

Stock Date P/S P/B P/E EV/EBIT
QTRX 2023-09-22 8.4 2.6 -14.3 -8.9
QTRX 2023-09-21 8.4 2.6 -14.3 -8.9
QTRX 2023-09-20 8.6 2.7 -14.6 -9.2
QTRX 2023-09-19 8.7 2.7 -14.8 -9.4
QTRX 2023-09-18 8.7 2.7 -14.8 -9.4
QTRX 2023-09-15 8.6 2.7 -14.7 -9.2

QTRX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • QTRX has a Quality Grade of D, ranking ahead of 13.4% of graded US stocks.
  • QTRX's asset turnover comes in at 0.276 -- ranking 59th of 75 Measuring and Control Equipment stocks.
  • 500 - Internal server error

The table below shows QTRX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.276 0.603 -0.474
2021-03-31 0.318 0.590 -0.489
2020-12-31 0.398 0.558 -0.511
2020-09-30 0.397 0.525 -0.611
2020-06-30 0.352 0.434 -1.038
2020-03-31 0.385 0.460 -1.276

QTRX Price Target

For more insight on analysts targets of QTRX, see our QTRX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $76.00 Average Broker Recommendation 1.42 (Moderate Buy)

Quanterix Corporation (QTRX) Company Bio

Quanterix Corporation develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and Asia Pacific. It develops Simoa HD-1 Analyzer, a sensitive protein detection platform, which analyzes approximately six biomarkers per test; and SR-X system that supports the detection capability of approximately six biomarkers per test. The company’s products also comprise kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, assay development, and custom development services. Quanterix Corporation primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was founded in 2007 and is based in Lexington, Massachusetts.

QTRX Latest News Stream

Event/Time News Detail
Loading, please wait...

QTRX Latest Social Stream

Loading social stream, please wait...

View Full QTRX Social Stream

Latest QTRX News From Around the Web

Below are the latest news stories about QUANTERIX CORP that investors may wish to consider to help them evaluate QTRX as an investment opportunity.

Here's Why Investors Should Buy Alcon (ALC) Stock Right Now

Investors continue to be optimistic about Alcon (ALC) on the impressive performance of its portfolio.

Yahoo | September 21, 2023

Here's Why You Should Retain Insulet (PODD) Stock for Now

Investors continue to be optimistic about Insulet (PODD) on the strength of the Omnipod 5 AID system.

Yahoo | September 15, 2023

Here's Why You Should Invest in Edward Lifesciences (EW) Now

Investors continue to be optimistic about Edward Lifesciences (EW) on the strength of TAVR and a solid balance sheet.

Yahoo | September 13, 2023

Here's Why You Should Retain Omnicell (OMCL) Stock Now

Investors are optimistic about Omnicell (OMCL), owing to the strong prospect of the advanced services portfolio.

Yahoo | September 6, 2023

Why You Should Add Haemonetics (HAE) to Your Portfolio Now

Haemonetics' (HAE) share price is likely to grow, backed by solid business performance across all its segments.

Yahoo | September 6, 2023

Read More 'QTRX' Stories Here

QTRX Price Returns

1-mo 4.60%
3-mo 14.32%
6-mo 139.08%
1-year 211.78%
3-year -20.84%
5-year 16.06%
YTD 87.29%
2022 -67.33%
2021 -8.82%
2020 96.78%
2019 29.06%
2018 -14.72%

Continue Researching QTRX

Want to see what other sources are saying about Quanterix Corp's financials and stock price? Try the links below:

Quanterix Corp (QTRX) Stock Price | Nasdaq
Quanterix Corp (QTRX) Stock Quote, History and News - Yahoo Finance
Quanterix Corp (QTRX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!